171 related articles for article (PubMed ID: 1356441)
21. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry.
Hasmann M; Valet GK; Tapiero H; Trevorrow K; Lampidis T
Biochem Pharmacol; 1989 Jan; 38(2):305-12. PubMed ID: 2914014
[TBL] [Abstract][Full Text] [Related]
22. New insights into the P-glycoprotein-mediated effluxes of rhodamines.
Loetchutinat C; Saengkhae C; Marbeuf-Gueye C; Garnier-Suillerot A
Eur J Biochem; 2003 Feb; 270(3):476-85. PubMed ID: 12542697
[TBL] [Abstract][Full Text] [Related]
23. Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone.
Jancis EM; Chen HX; Carbone R; Hochberg RB; Dannies PS
Biochem Pharmacol; 1993 Nov; 46(9):1613-9. PubMed ID: 7902090
[TBL] [Abstract][Full Text] [Related]
24. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
Borrel MN; Pereira E; Fiallo M; Garnier-Suillerot A
Eur J Biochem; 1994 Jul; 223(1):125-33. PubMed ID: 7518390
[TBL] [Abstract][Full Text] [Related]
25. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
27. Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs.
Hu Y; Moraes CT; Savaraj N; Priebe W; Lampidis TJ
Biochem Pharmacol; 2000 Dec; 60(12):1897-905. PubMed ID: 11108806
[TBL] [Abstract][Full Text] [Related]
28. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
29. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes.
Oselin K; Gerloff T; Mrozikiewicz PM; Pähkla R; Roots I
Fundam Clin Pharmacol; 2003 Aug; 17(4):463-9. PubMed ID: 12914549
[TBL] [Abstract][Full Text] [Related]
30. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
31. Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
Ludescher C; Eisterer W; Hilbe W; Hofmann J; Thaler J
Br J Haematol; 1995 Nov; 91(3):652-7. PubMed ID: 8555069
[TBL] [Abstract][Full Text] [Related]
32. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
34. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Lehne G; De Angelis P; Clausen OP; Rugstad HE
Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein.
Roepe PD
Biochemistry; 1992 Dec; 31(50):12555-64. PubMed ID: 1361758
[TBL] [Abstract][Full Text] [Related]
36. Effect of hyperthermia on rhodamine 123 cytotoxicity in doxorubicin-sensitive and doxorubicin-resistant human breast carcinoma cell lines in vitro.
Gritti A; Colombo A; Dasdia T; Melloni E; Marchesini R
Int J Hyperthermia; 1993; 9(3):393-401. PubMed ID: 8515142
[TBL] [Abstract][Full Text] [Related]
37. Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.
Pereira E; Borrel MN; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1994 Jan; 1225(2):209-16. PubMed ID: 7904185
[TBL] [Abstract][Full Text] [Related]
38. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.
Junco JJ; Mancha A; Malik G; Wei SJ; Kim DJ; Liang H; Slaga TJ
Mol Cancer Res; 2013 Dec; 11(12):1521-9. PubMed ID: 24072817
[TBL] [Abstract][Full Text] [Related]
40. Different storing and processing conditions of human lymphocytes do not alter P-glycoprotein rhodamine 123 efflux.
Chiva-Blanch G; Giménez-Bonafe P; Llaudó I; Torras J; Cruzado JM; Petriz J; Castaño E; Franquesa Ml; Herrero-Fresneda I; Tortosa A; Rama I; Bestard O; Grinyó JM; Lloberas N
J Pharm Pharm Sci; 2009; 12(3):357-66. PubMed ID: 20067710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
